The role of low dose rate brachytherapy in the treatment of cervix carcinoma. Experience of the Gustave-Roussy Institute on 1245 patients

A Gerbaulet; G Michel; C Haie-Meder; D Castaigne; E Lartigau; C L'Homme; P Duvillard; A Lusinchi; H Marsiglia; J Masselot

The role of low dose rate brachytherapy in the treatment of cervix carcinoma. Experience of the Gustave-Roussy Institute on 1245 patients

Eur J Gynaecol Oncol. 1995;16(6):461-75.

Authors

A Gerbaulet¹, G Michel, C Haie-Meder, D Castaigne, E Lartigau, C L'Homme, P Duvillard, A Lusinchi, H Marsiglia, J Masselot

Affiliation

¹ Department of Brachytherapy, Institut Gustave-Roussy, Villejuif, France.

PMID: 8536761

Abstract

From 1974 to 1992, 1245 patients with cervix carcinoma were treated at the Institut Gustave-Roussy using several treatment protocols all of which included LDR brachytherapy. We present and discuss the results of our experience.

MeSH terms

Adult
Brachytherapy / methods*
Clinical Trials as Topic
Combined Modality Therapy
Dose-Response Relationship, Radiation
Female
Humans
Middle Aged
Neoplasm Staging
Uterine Cervical Neoplasms / drug therapy
Uterine Cervical Neoplasms / radiotherapy*
Uterine Cervical Neoplasms / surgery